Hosted on MSN11mon
AbbVie reports findings from giant cell arteritis therapy trial
in combination with a steroid taper regimen in adults with giant cell arteritis (GCA). The multicentre, randomised, double-blind, placebo-controlled trial enrolled 428 patients. Divided into two ...
BBC6y
What is giant cell arteritis and how can I recognise it?
Giant cell arteritis, or GCA, is a condition where arteries in the head and neck become inflamed. It is called ‘giant cell’ because abnormally large cells accumulate in the artery walls.
Morningstar18d
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults with Giant Cell Arteritis
double-blind placebo-controlled study designed to evaluate the safety and efficacy of upadacitinib in 428 patients with GCA. The study consists of two periods. The first period, which is reported ...
Pharmabiz15d
EMA committee recommends approval of AbbVie’s upadacitinib to treat adults with giant cell arteritis
EMA committee recommends approval of AbbVie’s upadacitinib to treat adults with giant cell arteritis: North Chicago, Illinois Monday, March 3, 2025, 15:00 Hrs [IST] AbbVie annou ...